• Sonuç bulunamadı

Modified quadruple therapy or bismuth-containing quadruple therapy in the first-line treatment of Helicobacter Pylori in Turkey.

N/A
N/A
Protected

Academic year: 2021

Share "Modified quadruple therapy or bismuth-containing quadruple therapy in the first-line treatment of Helicobacter Pylori in Turkey."

Copied!
12
0
0

Yükleniyor.... (view fulltext now)

Tam metin

Şekil

Table 1. Demographic and clinical characteristics of patients

Referanslar

Benzer Belgeler

We thank the authors for the interest they have shown in our article entitled “Successful treatment of a pulmonary embolism with low-dose prolonged infusion of tissue-type

Rheumatoid arthritis (Rheumatoid arthritis, RA) is an ancient and full of mysterious autoimmune disease. Although a detailed knowledge of the pathogen has not yet systemic disease,

Sonuç: İlk basamak H.pilori eradikasyonunda 7 gün sü- reyle verilen levofloksasin temelli üçlü tedavi yeterince etkin değildir.. Yeni tedavi protokollerine ihtiyaç

Bu çalışmada çeşitli nedenlerle Erzurum Bölge Eğitim ve Araştırma Hastanesi’ne başvuran hasta- lardan alınan endoskopik antrum biyopsi sonuçla- rında H.pylori

İlk grupta 14 gün klasik üçlü tedavi (klaritromisin 2x500 mg, amoksisilin 2x1 gr ve proton pompa inhibitörü 2x1) (n:40), ikinci grupta 14 gün klasik üçlü tedavi ve

Objective: In this study, we evaluated the efficacy of NAC in dyspepsia symptoms in Helicobacter pylori (H. pylori) negative dyspeptic patients.. Materials and Methods: In

pylori infected children with first (ALC; amoxicillin, lansoprozole, clarithromycin) and second (MDBL; metranidazole, doxycycline, bismuth subcitrate, lansoprozole) line

Helicobacter pylori isolates recovered from antral gastric biopsies of patients with dyspeptic symptoms: Antimicrobial resistance of metronidazole, clarithromycin